Physician

James Matthew Tracey, MD

According to 2025 Medicare claims, James Tracey, MD (NPI: 1598102527) practices urology in the Wausau, WI market, with the plurality of this provider's patient population coming from Marathon, WI. This provider's primary affiliated billing organization is ASPIRUS MEDICAL GROUP, INC. (NPI: 1083289946; TIN: 391670223) and primary practice location at 54401-4710.

Tracey's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 241 traditional Medicare patients, billed 1,690 HCPCS/CPT codes, and received $104,602 in Medicare payments. The top billing code was 52000 (Diagnostic exam of bladder and urethra using an endoscope). Part D data shows 389 prescription claims across 174 beneficiaries totaling $15,953 in drug costs, led by Gemtesa (Vibegron). DME data shows 65 claims. Open Payments data shows 15 records totaling $668. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $8,942 and ending at $15,953. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	29	40	$3,390
2019	N/R	N/R	N/R
2020	268	3,170	$97,074
2021	346	3,687	$147,167
2022	368	3,530	$167,162
2023	245	1,967	$110,824
2024	241	1,690	$104,602

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	59	92	$8,942
2016	61	137	$4,446
2017	22	40	$3,381
2018	21	42	$6,722
2019	N/R	N/R	N/R
2020	200	597	$20,155
2021	286	1,096	$40,406
2022	304	1,008	$26,584
2023	217	510	$23,255
2024	174	389	$15,953

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	12	$1,307
2021	N/R	54	$4,169
2022	N/R	95	$15,373
2023	N/R	110	$16,120
2024	N/R	65	$4,050

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
52000	Diagnostic exam of bladder and urethra using an endoscope	86	120	$149
52332	Insertion of stent in ureter using an endoscope	27	34	$99
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	61	66	$95
51798	Ultrasound measurement of bladder capacity after voiding	30	33	$8
51741	Electronic assessment of bladder emptying	24	25	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gemtesa	Vibegron	12	360	$5,489
Tamsulosin Hcl	Tamsulosin Hcl	111	6,273	$1,083
Oxybutynin Chloride Er	Oxybutynin Chloride	25	1,635	$456
Oxybutynin Chloride	Oxybutynin Chloride	75	624	$387
Finasteride	Finasteride	31	2,221	$262

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	21	$2,590
A4349	Male external catheter, with or without adhesive, disposable, each	N	N/R	12	$827
A4357	Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, each	N	N/R	18	$582
A4332	Lubricant, individual sterile packet, each	N	N/R	14	$50

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	15	$668	Teleflex LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James Matthew Tracey, MD?

Tedicare shows public-source Medicare data for James Matthew Tracey, MD (NPI 1598102527), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Matthew Tracey, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to James Matthew Tracey, MD?

James Matthew Tracey, MD is linked to ASPIRUS MEDICAL GROUP, INC. (billing NPI 1083289946) in the available physician profile data.

Does James Matthew Tracey, MD have Open Payments data?

James Matthew Tracey, MD has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.